BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 25, 2014
View Archived Issues
FDA grants orphan drug status to cannabidiol for pediatric schizophrenia
Read More
Proteo discloses results from phase II study of Elafin in myocardial reperfusion injury
Read More
Small-molecule MIF inhibitors tested in the collagen-induced arthritis mouse model
Read More
Novogen identifies lead ATM drug candidate
Read More
First clinical data showed that KTN-3379 is well tolerated in advanced solid tumors
Read More
Early results for E-7438 show response in patients with lymphoma and advanced solid tumors
Read More
In vivo data for novel P. falciparum multi-antigen, multistage adenovirus vectored vaccine
Read More
Max-Planck-Gesellschaft and BTI divulge natural PPAR modulators
Read More
Sanofi develops novel CD38 inhibitors
Read More
Principia Biopharma reports discovery of FGFR inhibitors
Read More
EMA issues new recommendations for the use of Corlentor/Procoralan
Read More
CHMP recommends granting marketing authorization for Shionogi's Senshio
Read More
Merck & Co. and NewLink Genetics collaborate on investigational Ebola vaccine
Read More
EMA committee recommends approval of Travatan for use in pediatric patients
Read More
Amgen terminates all Amgen-sponsored studies of rilotumumab in advanced gastric cancer
Read More
Primary endpoint met in phase II study of TriMix-DC-MEL melanoma vaccine
Read More
Janssen files NDA for Yondelis for advanced soft tissue sarcoma
Read More
Merck & Co. files for Japanese approval of omarigliptin for type 2 diabetes
Read More
NPS Pharmaceuticals' teduglutide receives orphan drug status in Japan for short bowel syndrome
Read More
Synthetic Biologics cleared to begin phase I trials of SYN-004
Read More
FDA awards orphan drug designation to CAT-1004 for Duchenne muscular dystrophy
Read More
FDA grants QIDP designations to Bayer's Amikacin Inhale and ciprofloxacin DPI
Read More
Bristol-Myers Squibb and Five Prime to evaluate combination of Opdivo and FPA-008
Read More
Vorapaxar receives positive opinion from EMA
Read More
Juno Therapeutics' JCAR-015 designated a Breakthrough Therapy by FDA
Read More
